All Stories

  1. Pharmacognosy: Importance and Drawbacks
  2. Addressing knowledge gaps in molecular, sero-surveillance and monitoring approaches on Zika epidemics and other arbovirus co-infections: A structured review
  3. Can free open access resources strengthen knowledge-based emerging public health priorities, policies and programs in Africa?
  4. Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People’s Republic of China
  5. Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance
  6. Asexual and sexual stages of Plasmodium falciparum in Nigerian pregnant women attending antenatal booking clinic
  7. Clinical Profiles of Newborns with Malaria Parasitaemia in Sagamu
  8. Activities of Artesunate and Amodiaquine against Intestinal Helminth in Children with Plasmodium falciparum Malaria in Endemic Area
  9. Herpes simplex labialis in children with acute falciparum malaria
  10. Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas
  11. Activities of Artemether-Lumefantrine and Amodiaquine-Sulfalene-Pyrimethamine against Sexual-Stage Parasites in Falciparum Malaria in Children
  12. Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children
  13. Comparative Study of Efficacy of Amodiaquine-Cotrimoxazole and Amodiaquine-Pyrimethamine Sulphadoxine in the Treatment of Malaria in Nigerian Children
  14. Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo
  15. Activities of Amodiaquine, Artesunate, and Artesunate-Amodiaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria in Children
  16. Effects of acute Plasmodium falciparum malaria on body weight in children in an endemic area
  17. Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children
  18. The effects of artemether–lumefantrine vs amodiaquine–sulfalene–pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children
  19. Predictors of the failure of treatment with pyrimethamine–sulfadoxine in children with uncomplicated falciparum malaria
  20. Predictors of the failure of treatment with trimethoprim–sulfamethoxazole in children with uncomplicated, Plasmodium falciparum malaria
  21. Response to chloroquine treatment in children with or without gametocytes during uncomplicated Plasmodium falciparum malaria
  22. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children
  23. Plasmodium falciparum Malaria in Nigerian Children During High and Low Transmission Seasons: Gametocyte Carriage and Response to Oral Chloroquine
  24. Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated,Plasmodium falciparummalaria, in an area with high and increasing incidences of chloroquine resistance
  25. Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
  26. Predictors of the failure of treatment with chloroquine plus chlorpheniramine, in children with acute, uncomplicated,Plasmodium falciparummalaria
  27. Comparative effects of pyrimethamine–sulfadoxine, with and without probenecid, onPlasmodium falciparumgametocytes in children with acute, uncomplicated malaria
  28. Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children
  29. Plasmodium falciparumhyperparasitaemia in children
  30. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children
  31. Cotrimoxazole in the Treatment of Acute Uncomplicated Falciparum Malaria in Nigerian Children
  32. The effects of chloroquine, amodiaquine and chloroquine plus chlorpheniramine on the disposition kinetics of the hepatomegaly associated with acute, uncomplicated,Plasmodium falciparummalaria in children
  33. Comparative clinical characteristics and responses to oral 4-aminoquinoline therapy of malarious children who did and did not develop 4-aminoquinoline-induced pruritus
  34. Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children
  35. Analgesic activity of Peperomia pellucida aerial parts in mice
  36. Clinical characteristics and disposition kinetics of the hepatomegaly associated with acute, uncomplicated, Plasmodium falciparum malaria in children
  37. Comparison of Artemether and Artemether plus Mefloquine in Children with Malaria and Effects on Viability of Plasmodium falciparum Ex vivo
  38. Comparative Plasmodium falciparum Kinetics during Treatment with Amodiaquine and Chloroquine in Children
  39. Pharmacological Screening of a Methanol Extract from Mormodica charantia in Rodents
  40. Comparative Efficacy and Safety of Two Regimens of Chlorpheniramine plus Chloroquine in Acute Uncomplicated Falciparum Malaria in Children
  41. Patterns of Change in the Electrocardiogram after Halofantrine Treatment of Acute Uncomplicated Falciparum Malaria in Children
  42. Comparative clinical characteristics and response to oral antimalarial therapy of children with and withoutPlasmodium falciparumhyperparasitaemia in an endemic area
  43. Plasmodium falciparum Kinetics during Treatment with Antimalarial Drugs in Children
  44. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine–pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children